UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Focusing on short term investment goals can yield quick financial returns. Discover the right timing for your investment strategy.
27,474 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
In a renewed push to accumulate, Strategy added 1,550 BTC for about $101 million in early June, boosting holdings to ...
A new bipartisan proposal would create a formal commission to study the long-term finances of Social Security and Med...
Microsoft shifts core apps to its MAI system, pressuring margins while Google leans on in‑house silicon and Gemini. A...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
NVIDIA leads the AI hardware wave while Palantir gains momentum on enterprise software. Investors debate which stock ...
wlfi holders dump 1.8b tokens in a record profit event on May 18, underscoring a sharp shift in the token’s owner bas...
Analysts are weighing a path for synopsys stock $600 march targets as AI-driven chip design demand grows, even as deb...
Cardano’s founder positions AI agents as essential infra for Midnight City, while ADA hovers near $0.16 as traders we...
Blue Origin is pursuing a $130 billion private-market valuation, signaling a bold push by jeff bezos’s space company ...
A wave of Wall Street financing is turning public Bitcoin miners into power-and-compute operators, as bitcoin mining ...
XRP exchange-traded funds booked their first monthly net outflow after a $1.2 billion rally, signaling a shift in inv...